120例肝癌患者使用替雷利珠单抗致免疫相关不良事件分析
梁方林, 陈玲园, 胡丹荔, 韦玲云, 韦铁猛, 张发恩, 韦亚娜
Immune-Related Adverse Events of Tislelizumab in 120 Patients with Hepatocellular Carcinoma
LIANG Fanglin, CHEN Lingyuan, HU Danli, WEI Lingyun, WEI Tiemeng, ZHANG Faen, WEI Yana
中国药物警戒
.
2025, (6): 659
-663
.
DOI: 10.19803/j.1672-8629.20240987
